RNA droplets to transfer biological signals, opening opportunities for safer, more effective RNA, gene, and protein therapies ...
OpenProtein.AI is helping biologists stay on the cutting edge of AI with a no-code platform for protein engineering.
Akamis Bio, a clinical-stage oncology company working to advance the standard of care in colorectal cancer, today announced early data from the on-going Phase 1b FORTRESS study of NG-350A, an ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results